Ryner Lai, MBBS

All articles by Ryner Lai, MBBS

• The liver’s role in bilirubin processing and hemolysis

  Learn more about how the liver processes bilirubin and what happens if an infant has excess bilirubin, which is common in HDFN.

• Infants with HDFN more likely to be born premature

  The study authors stated patients at risk of HDFN must be closely monitored throughout pregnancy to improve outcomes.

• Researchers pinpoint three new biomarkers linked to HDFN

  Researchers identified three biomarkers that are raised in patients with HDFN associated with ABO incompatibility.

• Study finds anti-D prophylaxis can be safely prescribed by midwives

  Anti-D prophylaxis can be safely prescribed and administered to pregnant women in community pharmacies.

• Why haptoglobin levels are often low in infants with HDFN

  Learn more about haptoglobin, including what it is, how it works and why infants with HDFN often have low haptoglobin levels.

• Fenofibrate therapy may lower bilirubin levels in newborn jaundice

  Fenofibrate therapy was shown to be effective in treating neonatal jaundice.

• Where to find medical research and studies about HDFN

  Learn about where and how to find information related to HDFN research, diagnosis, clinical trials and treatments.

• Reducing HDFN risk after mismatched RhD blood transfusions

  RhD mismatch remains a significant problem in pregnancies affected by HDFN.

• Non-invasive jaundice test shows promise in recent study

  Transcutaneous bilirubinometry is a non-invasive manner for measuring newborn bilirubin levels that do not require the insertion of needles.

• IVIG, IUTs recommended to treat fetal anemia in early-onset HDFN

  Medical interventions such as intrauterine transfusions and immune therapies may be necessary in pregnant women at risk of early-onset HDFN.